Tokyo: Life Sciences and Health Care Horizons 2019

Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.

Exciting Trends in Japanese Tech M&A

In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...

Going Global 2018

Cross-practice, multi-track seminar on advanced trademark issues, global M&A transactions, global patent updates for technology companies, energy investments, and recent...

Going Global 2017

We are hosting a cross-practice, multi-track seminar on November 16 (Tokyo) and November 13 (Osaka). Join us to find out about a new approach to brand management, the latest developments in ...

Japan In-House Lawyers Association Seminar: A Global Perspective on avoiding Bribery and Corruption Pitfalls

One of the key risks that Japanese companies face as they expand their businesses overseas is cartel, corruption and bribery risks. Companies need to be aware of these risks especially when ...

The Global Antitrust Corner – Circumnavigating the Merger Control World

Global M&A activity has continued at a steady pace in 2015, with an increasing number of transactions raising antitrust issues under multiple merger control regimes. Beyond the U.S. and ...

Loading data